… treatment in adult subjects of partial-onset seizures, with or without secondary generalization.
… on eslicarbazepine acetate in the treatment of drug-resistant partial epilepsy. Efficacy and …

… effectiveness of eslicarbazepine acetate (ESL) in the treatment of patients with refractory
epilepsy. … focal-onset epilepsy with a good safety profile. Evaluation of its use for treating other …

… safety of eslicarbazepine acetate (ESL) as adjunctive treatment in adult patients with focal
onset seizures… -pass hydrolysis to the active metabolite eslicarbazepine, which has linear, dose…

OBJECTIVE: To evaluate the long-term safety, tolerability and efficacy of once-daily eslicarbazepine
acetate (ESL) as adjunctive therapy in adults with partial-onset seizures. METHODS…

… To investigate the efficacy and safety of once-daily eslicarbazepine acetate (ESL) when
used as add-on treatment in adults with ≥4 partial-onset seizures per 4-week despite treatment …

… safety set. The most frequently reported serious TEAEs included status epilepticus and
epilepsy in the eslicarbazepine acetate … injury, inguinal hernia, partial seizures, and pulmonary …

… setting the long-term efficacy and safety of ESL in patients with focal seizures. … Eslicarbazepine
acetate as adjunctive therapy in patients with refractory partial-onset seizures: safety …

… Purpose: To evaluate the long-term efficacy and safety of once daily eslicarbazepine
acetate (ESL) as adjunctive therapy for partial-onset seizures in adults with epilepsy. …

… safety of one of the three pivotal studies with ESL as adjunctive therapy in adults with refractory
partial-onset seizures… are based on comparison between eslicarbazepine acetate (ESL) …

… safety profile of eslicarbazepine acetate (ESL) added to stable antiepileptic therapy in adults
with partial-onset seizures. … Seizure frequency and relative reduction of seizure frequency …